Influence of coexisting Hashimoto thyroiditis on the postoperative residual thyroid tissue ablation success after the first dose of 3.7 GBq of iodine-131 in patients with differentiated thyroid carcinoma

被引：0
|
作者：
Rajic, M. P. [1 ]
Vlajkovic, M. [1 ]
Ilic, S. [1 ]
Stevic, M. [1 ]
Misic, I. [1 ]
Kojic, M. [1 ]
机构：
[1] Univ Nis, Sch Med, Nish, Serbia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0823
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [21] Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
    Françoise Aubène Leger
    Mireille Izembart
    Françoise Dagousset
    Lionel Barritault
    Georges Baillet
    Alain Chevalier
    Jérôme Clerc
    European Journal of Nuclear Medicine, 1998, 25 : 242 - 246
  • [22] A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatment
    Azizmohammadi, Zahra
    Tabei, Faraj
    Shafiei, Babak
    Babaei, Ali Akbar
    Jukandan, Seyed Mohsen Qutbi
    Naghshine, Reza
    Javadi, Hamid
    Nabipour, Iraj
    Assadi, Majid
    Asli, Isa Neshandar
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2013, 16 (02): : 103 - 106
  • [23] Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma
    Muratet, JP
    Daver, A
    Minier, JF
    Larra, F
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1546 - 1550
  • [24] Evaluation of the Efficiency of 131I Ablative Dose of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Ben Sellem, D.
    Kraiem, T.
    Letaief, B.
    Ben Slimene, M. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S348 - S349
  • [25] Differentiated Thyroid Carcinoma After Iodine-131 Metaiodobenzylguanidine Treatment for Neuroblastoma: Assessment of Causality
    Teszler, Chris Barna
    THYROID, 2013, 23 (02) : 248 - 249
  • [26] Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma
    MKacher, R
    Legal, JD
    Schlumberger, M
    Aubert, B
    BeronGaillard, N
    Gaussen, A
    Parmentier, C
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (03) : 377 - 380
  • [27] Bone Marrow Radiation Dose in Thyroid Carcinoma Patients Treated with Iodine-131
    Parlak, Y.
    Demir, M.
    Erees, S.
    Gumuser, G.
    Uysal, B.
    Kaya, G. Capa
    Koc, M.
    Ergene, U.
    Sayit, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S436 - S436
  • [28] Ablation with Low-Dose(1.1GBq) and High-Dose(3.7GBq) Radioiodine in Postoperative Low and Intermediate Risk Differentiated Thyroid Cancer
    Qu, Yuan
    Huang, Rui
    Li, Lin
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [29] Does remnant from differentiated thyroid microcarcinoma patients really not be treated with Iodine-131 ablation?
    D'Antuono, F.
    Gallicchio, R.
    Venetucci, A.
    Nardelli, A.
    Giacomobono, S.
    Pellegrino, T.
    Tempone, A.
    Di Leo, A.
    Gattozzi, D.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S126 - S126
  • [30] Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study
    Zhang, Hong
    Cai, Yuechang
    Zheng, Li
    Zhang, Zhanlei
    Jiang, Ningyi
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2017, 20 (01): : 3 - 10
12345